A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age

Clinical trial NCT05085366 · TERMINATED

Trial details

NCT number: NCT05085366
Sponsor: ModernaTX, Inc.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Cytomegalovirus Infection

Start date: 2021-10-26
Primary completion: 2025-11-04
Enrollment: 7454

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.